ClearPoint Neuro Net Long-Term Debt 2010-2024 | CLPT
ClearPoint Neuro net long-term debt from 2010 to 2024. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
| ClearPoint Neuro Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $-10 |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $22 |
| 2019 | $-2 |
| 2018 | $-2 |
| 2017 | $N/A |
| 2016 | $N/A |
| 2015 | $N/A |
| 2014 | $4 |
| 2013 | $N/A |
| 2012 | $3 |
| 2011 | $2 |
| 2010 | $4 |
| 2009 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.389B | $0.031B |
| ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California. | |||